Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.860
+0.3202.36%
Volume:9.94M
Turnover:138.86M
Market Cap:12.04B
PE:126
High:14.360
Open:13.580
Low:13.580
Close:13.540
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.95
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.67
PE(LYR):126.00
PS:8.57

Loading ...

HBM HOLDINGS-B Receives Regulatory Clearance for Asthma Drug Trial

Stock News
·
Jul 15

China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575

Reuters
·
Jul 15

Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech

THOMSON REUTERS
·
Jul 15

Hbm Holdings - Nmpa Approves Ind Application for Hbm7575 for Asthma

THOMSON REUTERS
·
Jul 15

HBM Holdings Monthly Return: Issued Shares Edge Up 0.08% on Option Exercises; Public Float Maintained

Bulletin Express
·
Jul 07

HBM Holdings (SEHK:2142) Teams Up With Lonza, Is The Stock Already Fully Valued?

Simply Wall St.
·
Jul 04

Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-class Single-domain Antibody-based Bbb-crossing Technology for CNS Diseases

THOMSON REUTERS
·
Jul 02

Shanghai Court Dismisses HBM Subsidiary's Patent Infringement Claim Against Biocytogen

MT Newswires Live
·
Jun 29

Harbour Biomed Appoints Lloyd Klickstein Scientific Advisor for Immunology

Reuters
·
Jun 29

HBM Holdings Annual Meeting: All Eight Resolutions Secure Strong Shareholder Support

Bulletin Express
·
Jun 25

HBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement

Stock News
·
Jun 17

HBM Holdings and Baidu's Biotech Arm Forge AI Drug Discovery Alliance, Launching MegaStream TechBio

Stock News
·
Jun 15

HBM Holdings partners with BioMap to co-found AI drug R&D venture MegaStream TechBio

Reuters
·
Jun 15

Hbm - Co and Biomap to Jointly Initiate Megastream Techbio

THOMSON REUTERS
·
Jun 15

Hbm - Co and Biomap Enter Global Strategic Partnership for AI-Driven Biologics

THOMSON REUTERS
·
Jun 15

HBM Holdings-B Prevails in Patent Infringement Case Against Amgen, Awarded Approximately $20.2 Million with Potential for Triple Damages

Stock News
·
Jun 15

Harbour Biomed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

THOMSON REUTERS
·
Jun 15

HBM Holdings wins US patent jury verdict against Amgen, awarded USD 20.2 million damages

Reuters
·
Jun 15

Hbm - Jury Returns Verdict in Favor of Harbour Antibodies Against Amgen in U.S. Patent Case

THOMSON REUTERS
·
Jun 15

Hbm Holdings - Jury Verdict in U.S. Patent Infringement Litigation

THOMSON REUTERS
·
Jun 15